论文部分内容阅读
目的探讨阿托伐他汀对慢性心力衰竭的治疗效果。方法选取2013年2月至2015年2月慢性心力衰竭患者132例,依据治疗方案分为两组,每组66例。比较两组血脂指标及治疗效果。结果阿托伐组治疗后左室射血分数较治疗前明显升高,总胆固醇、C-反应蛋白较治疗前降低,与常规组治疗后比较差异有统计学意义(P<0.05)。阿托伐组总有效率(84.84%)优于常规组(59.09%),差异有统计学意义(P<0.05)。结论阿托伐他汀治疗慢性心力衰竭的效果显著,能改善患者心功能,降低再住院率,可临床推广应用。
Objective To investigate the therapeutic effect of atorvastatin on chronic heart failure. Methods 132 patients with chronic heart failure from February 2013 to February 2015 were selected and divided into two groups according to the treatment plan, 66 cases in each group. Compare the two groups of blood lipid indicators and treatment effect. Results Atorvastatin group after treatment, left ventricular ejection fraction was significantly higher than before treatment, total cholesterol, C-reactive protein decreased compared with before treatment, compared with the conventional group after treatment was statistically significant (P <0.05). The total effective rate (84.84%) in the atorvastatin group was superior to that in the conventional group (59.09%), with significant difference (P <0.05). Conclusions Atorvastatin is effective in treating chronic heart failure and can improve cardiac function and reduce the rate of rehospitalization, which can be popularized clinically.